Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline-controlled trial; up to $2.6 million in non-dilutive funding anticipated o ...
At Barton Creek Technologies, Anna Chen, the chief human resources officer, faces a dilemma over the company’s performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback